The smart … in this case “ inside “ money like Lars Ekman , got his fund out of AMRN when he knew the increased rebates the Co was making would mean a bigger then expected quarterly loss …. Before Co posted their Qtly
BVF may have had the same info
Baker Bros and Denner didn’t sell did they ?
Aren’t they the “ smart money “
I’ve posted this before so just going from memory
AMRN has over $300 m cash and investments they can turn into cash
They have over $300 m in inventory
They have little to no debt
As long as they can reduce their cash spend ( fewer US sales reps , roll over to lower API purchase agreements etc ) …they are not going bankrupt anytime soon
They only go bankrupt IMHO if they fail to get reimbursement with low copays in the UK / EU
TA question for U … if the Naz / S&P etc make new lows , but your stock ( AMRN ) doesn’t … is that a positive divergence ?
Kiwi